![James A. Breckenridge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James A. Breckenridge
Fondatore presso Med Opportunity Partners LLC
Profilo
Mr. James A.
Breckenridge is Partner & Co-Founder at Med Opportunity Partners LLC.
Prior to the formation of the firm, Mr. Breckenridge was Partner at UBS Capital Americas.
He joined UBS Capital Americas in 1993 he has overseen and participated in private equity transactions across a wide variety of industries including Healthcare, Medical Devices & Products, Performance Chemicals and General Industrial.
He is currently a generalist and serves on the Board of Directors of Avail Medical.
Prior to joining UBS Capital Americas Mr. Breckenridge worked in the Equity research department of Kidder, Peabody & Company Inc. following food, beverage and tobacco industries.
Mr. Breckenridge graduated from Colgate University and received his MBA from Columbia University Graduate School of Business.
He serves as a director of Avail Medical Products, Inc.
Posizioni attive di James A. Breckenridge
Società | Posizione | Inizio |
---|---|---|
Med Opportunity Partners LLC
![]() Med Opportunity Partners LLC Investment ManagersFinance Med Opportunity Partners LLC is a private equity firm founded in 2006 by Robert Vaters, Vicente Trelles and James Breckenridge headquarter is in Connecticut United States. | Fondatore | 11/12/2010 |
Pfanstiehl, Inc.
![]() Pfanstiehl, Inc. Pharmaceuticals: MajorHealth Technology Pfanstiehl, Inc. develops endotoxin injectable formulation and pharmaceutical ingredients. The firm specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin injectable formulation ingredients, pharmaceutical intermediates and active pharmaceutical ingredients. The company was founded by Carl A. Pfanstiehl in 1919 and is headquartered in Waukegan, IL. | Presidente | 01/01/2017 |
Precedenti posizioni note di James A. Breckenridge
Società | Posizione | Fine |
---|---|---|
UBS Capital Americas LLC
![]() UBS Capital Americas LLC Investment ManagersFinance Spun out of UBS AG (NYSE: UBS) in 2000, UBS Capital Americas LLC is a private equity firm based in New York City | Analista di Private Equity | 31/12/2006 |
Kidder, Peabody & Co., Inc.
![]() Kidder, Peabody & Co., Inc. Investment Banks/BrokersFinance Kidder, Peabody & Co., Inc. provides security brokerage services. The private company is based in Buffalo, NY and has subsidiaries in Switzerland. The company was founded by Thomas W. Ostrander. | Corporate Officer/Principal | - |
Formazione di James A. Breckenridge
Colgate University | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
UBS Capital Americas LLC
![]() UBS Capital Americas LLC Investment ManagersFinance Spun out of UBS AG (NYSE: UBS) in 2000, UBS Capital Americas LLC is a private equity firm based in New York City | Finance |
Med Opportunity Partners LLC
![]() Med Opportunity Partners LLC Investment ManagersFinance Med Opportunity Partners LLC is a private equity firm founded in 2006 by Robert Vaters, Vicente Trelles and James Breckenridge headquarter is in Connecticut United States. | Finance |
Kidder, Peabody & Co., Inc.
![]() Kidder, Peabody & Co., Inc. Investment Banks/BrokersFinance Kidder, Peabody & Co., Inc. provides security brokerage services. The private company is based in Buffalo, NY and has subsidiaries in Switzerland. The company was founded by Thomas W. Ostrander. | Finance |
Pfanstiehl, Inc.
![]() Pfanstiehl, Inc. Pharmaceuticals: MajorHealth Technology Pfanstiehl, Inc. develops endotoxin injectable formulation and pharmaceutical ingredients. The firm specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin injectable formulation ingredients, pharmaceutical intermediates and active pharmaceutical ingredients. The company was founded by Carl A. Pfanstiehl in 1919 and is headquartered in Waukegan, IL. | Health Technology |
- Borsa valori
- Insiders
- James A. Breckenridge